Literature DB >> 12062990

War and gerbils compound Afghan leishmaniasis epidemic.

Khabir Ahmad.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12062990     DOI： 10.1016/s1473-3099(02)00284-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

Review 1.  [Epidemiology and prevention of leishmaniasis in northern Afghanistan].

Authors:  M K Faulde; K Erkens; R Dieterle
Journal:  Hautarzt       Date:  2015-05       Impact factor: 0.751

2.  Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

Authors:  Pieter-Paul van Thiel; Tjalling Leenstra; Henry J de Vries; Allard van der Sluis; Tom van Gool; Alex C Krull; Michèle van Vugt; Peter J de Vries; Jimmy E Zeegelaar; Aldert Bart; Wendy F van der Meide; Henk D F H Schallig; William R Faber; Piet A Kager
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

3.  Zoonotic cutaneous leishmaniasis, Afghanistan.

Authors:  Michael K Faulde; Gerhard Heyl; Mohammed L Amirih
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

Review 4.  Rodent Ectoparasites in the Middle East: A Systematic Review and Meta-Analysis.

Authors:  Md Mazharul Islam; Elmoubashar Farag; Khalid Eltom; Mohammad Mahmudul Hassan; Devendra Bansal; Francis Schaffner; Jolyon M Medlock; Hamad Al-Romaihi; Zilungile Mkhize-Kwitshana
Journal:  Pathogens       Date:  2021-01-31

5.  Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa.

Authors:  Rebecca Du; Peter J Hotez; Waleed S Al-Salem; Alvaro Acosta-Serrano
Journal:  PLoS Negl Trop Dis       Date:  2016-05-26

Review 6.  A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

Authors:  Waleed Al-Salem; Jennifer R Herricks; Peter J Hotez
Journal:  Parasit Vectors       Date:  2016-08-22       Impact factor: 3.876
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.